0
Communications to the Editor |

Xinafoic Acid Is Not a Solvent for Salmeterol FREE TO VIEW

Malcolm Johnson, MD
Author and Funding Information

Glaxo Wellcome, Uxbridge, Middlesex, UK

Correspondence to: Malcolm Johnson, PhD, Glaxo Wellcome Research and Development, Stockley Park, Uxbridge, Middlesex, UB11 1BT, UK



Chest. 1999;116(4):1138. doi:10.1378/chest.116.4.1138
Text Size: A A A
Published online

To the Editor

I have read with interest the recent article by Groeben and Emala, “Is β-Adrenergic-Mediated Airway Relaxation of Salmeterol Antagonized by Its Solvent Xinafoic Acid?” (June 1999).1 There is an important and misleading error in both the title and in the body of the text of this paper. Xinafoic acid is not the solvent for salmeterol; it is, in fact, the salt form of salmeterol xinafoate. However, the terms “solvent” and “vehicle solvent” are used extensively throughout the manuscript.

There is no free xinafoic acid in the marketed product, Serevent (GlaxoWellcome; Research Triangle Park, NC), or, indeed, any that is formed in vivo at physiologic pH when the drug is administered therapeutically. Extrapolations that the authors make with regard to “clinically relevant concentrations of xinafoic acid” and to agents “associated with occupational asthma” and “contribution to fatalities” are erroneous and not justified.

Although the authors conclude that xinafoic acid has no effect on the pharmacology of salmeterol, it is disappointing that a prestigious journal like CHEST would fail in its review process and allow an error of basic chemistry to enter the literature. We are equally concerned that respiratory physicians, who see CHEST as one of the key journals for information in their field, will now think that Serevent contains a “solvent” when administering the drug to their patients.

References

Groeben, H, Emala, C (1999) Is β-adrenergic-mediated airway relaxation of salmeterol antagonized by its solvent xinafoic acid?Chest115,1678-1683. [PubMed] [CrossRef]
 

Figures

Tables

References

Groeben, H, Emala, C (1999) Is β-adrenergic-mediated airway relaxation of salmeterol antagonized by its solvent xinafoic acid?Chest115,1678-1683. [PubMed] [CrossRef]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543